NovaBay Pharmaceuticals Inc. is a clinical stage pharmaceutical Company engaged in the discovery and development of innovative product candidates for the treatment or prevention of a range of infections in hospital and non-hospital environments.


Updates from The Motley Fool

Latest updates on NOVABAY PHARMACEUTICALS, INC. from Fool.com.


Stock Performance

View Interactive NBY Charts
Sponsored by

Key Data Points

Primary metrics and data points about NOVABAY PHARMACEUTICALS, INC..
Current Price: $3.80
Prev Close: $3.80
Open: $3.75
Bid: $3.70
Ask: $4.40
Day's Range: $3.70 - $3.85
52wk Range: $1.86 - $5.29
Volume: 35,909
Avg Vol 18,004
Market Cap: $58M
P/E (ttm): -1.42
EPS (ttm): ($2.68)
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about NOVABAY PHARMACEUTICALS, INC..
CAPS Rating 1 out of 5
 
17 Outperform
5 Underperform
CAPS All Stars
 
4 Outperform
3 Underperform

How do you think NOVABAY PHARMACEUTICALS, INC. will perform against the market?



You pick for NOVABAY PHARMACEUTICALS, INC. is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Ron Najafi, CEO

90% Approve

Based on 9 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for NOVABAY PHARMACEUTICALS, INC..

NovaBay Pharmaceuticals Inc. is a clinical stage pharmaceutical Company engaged in the discovery and development of innovative product candidates for the treatment or prevention of a range of infections in hospital and non-hospital environments.

  • Exchange: NYSEMKT
  • Sector: Healthcare
  • Industry: Drug Makers